The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(1-(2-Aminopyrimidin-4-yl)-1H-pyrozolo[4,3-c]pyridin-6-yl)-phenol ID: ALA5287032
Max Phase: Preclinical
Molecular Formula: C16H12N6O
Molecular Weight: 304.31
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nccc(-n2ncc3cnc(-c4ccc(O)cc4)cc32)n1
Standard InChI: InChI=1S/C16H12N6O/c17-16-18-6-5-15(21-16)22-14-7-13(19-8-11(14)9-20-22)10-1-3-12(23)4-2-10/h1-9,23H,(H2,17,18,21)
Standard InChI Key: MIYHFQGUXXSBLI-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
3.7391 -5.5639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4559 -5.1504 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4531 -4.3194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7374 -3.9100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0240 -5.1508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0252 -4.3215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2368 -4.0639 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7483 -4.7342 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2348 -5.4058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9830 -3.2786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5367 -2.6675 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2835 -1.8827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4755 -1.7092 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9214 -2.3268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1776 -3.1092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8370 -1.2705 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1663 -3.9039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8800 -4.3170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5927 -3.9023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5901 -3.0760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8687 -2.6662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1588 -3.0832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3028 -2.6596 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
12 16 1 0
3 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 304.31Molecular Weight (Monoisotopic): 304.1073AlogP: 2.17#Rotatable Bonds: 2Polar Surface Area: 102.74Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.54CX Basic pKa: 5.50CX LogP: 2.11CX LogD: 2.10Aromatic Rings: 4Heavy Atoms: 23QED Weighted: 0.59Np Likeness Score: -1.05
References 1. Halkina T, Henderson JL, Lin EY, Himmelbauer MK, Jones JH, Nevalainen M, Feng J, King K, Rooney M, Johnson JL, Marcotte DJ, Chodaparambil JV, Kumar PR, Patterson TA, Murugan P, Schuman E, Wong L, Hesson T, Lamore S, Bao C, Calhoun M, Certo H, Amaral B, Dillon GM, Gilfillan R, de Turiso FG.. (2021) Discovery of Potent and Brain-Penetrant Tau Tubulin Kinase 1 (TTBK1) Inhibitors that Lower Tau Phosphorylation In Vivo., 64 (9.0): [PMID:33944571 ] [10.1021/acs.jmedchem.1c00382 ]